These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9544316)

  • 1. Haemophilus influenzae vaccines: 1997.
    Murphy TV
    Adv Pediatr Infect Dis; 1997; 13():279-304. PubMed ID: 9544316
    [No Abstract]   [Full Text] [Related]  

  • 2. Why the rise in Haemophilus influenzae type b infections?
    Silfverdal SA; Bodin L; Olcén P
    Lancet; 2003 Jul; 362(9380):331. PubMed ID: 12892974
    [No Abstract]   [Full Text] [Related]  

  • 3. Conjugate Hib vaccines.
    Steinhoff M; Goldblatt D
    Lancet; 2003 Feb; 361(9355):360-1. PubMed ID: 12573368
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemophilus disease in Alaskan and Canadian children.
    Bruce M; Singleton R; Lem M; Zulz T; Wenger J; Hennessy T
    Pediatr Infect Dis J; 2010 Feb; 29(2):186; author reply 186-7. PubMed ID: 20118746
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of functional Haemophilus influenzae type b antibodies after vaccination.
    van der Velden AM; Claessen AM; van Velzen-Blad H; Biesma DH; Rijker GT
    Haematologica; 2005 Nov; 90(11):1582-4. PubMed ID: 16266910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In brief: A new hib booster.
    Med Lett Drugs Ther; 2009 Nov; 51(1324):88. PubMed ID: 19890246
    [No Abstract]   [Full Text] [Related]  

  • 8. From the Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children-- United States, 1998-2000.
    JAMA; 2002 May; 287(17):2206-7. PubMed ID: 11987296
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycoconjugate vaccines against Haemophilus influenzae type b.
    Fernandez Santana V; Peña Icart L; Beurret M; Costa L; Verez Bencomo V
    Methods Enzymol; 2006; 415():153-63. PubMed ID: 17116473
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemophilus influenzae type B disease, vaccines, and care of exposed individuals.
    Burns IT; Zimmerman RK
    J Fam Pract; 2000 Sep; 49(9 Suppl):S7-13; quiz S14. PubMed ID: 11032188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Haemophilus influenzae type b carrier status among children 10 years after the introduction of Hib vaccine in Brazil.
    Zanella RC; Brandileone MC; Andrade AL; Ogassavara CT; Fiório CE; Brandão AP; Almeida SC; Lemos AP; Gorla MC; Carvalhanas TR; Sato H; Liphaus B; Nerger ML; Conde M; Ribeiro AF
    Mem Inst Oswaldo Cruz; 2015 Sep; 110(6):755-9. PubMed ID: 26517654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of multiple copies of the capsulation b locus in invasive Haemophilus influenzae type b (Hib) strains isolated from children with Hib conjugate vaccine failure.
    Cerquetti M; Cardines R; Ciofi Degli Atti ML; Giufré M; Bella A; Sofia T; Mastrantonio P; Slack M
    J Infect Dis; 2005 Sep; 192(5):819-23. PubMed ID: 16088831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b (Hib) Vaccination Position Paper – July 2013.
    Wkly Epidemiol Rec; 2013 Sep; 88(39):413-26. PubMed ID: 24143842
    [No Abstract]   [Full Text] [Related]  

  • 14. [Polysaccharide vaccines against Haemophilus influenzae type B].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of disease attributable to Haemophilus influenzae type b and the national immunization program.
    Meissner HC; Pickering LK
    Pediatrics; 2002 Oct; 110(4):820-3. PubMed ID: 12359800
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity.
    Goldblatt D
    Arch Dis Child; 2008 Aug; 93(8):646-7. PubMed ID: 18644932
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term trends in invasive Haemophilus influenzae type B disease among indigenous Australian children following use of PRP-OMP and PRP-T vaccines.
    Menzies RI; Bremner KM; Wang H; Beard FH; McIntyre PB
    Pediatr Infect Dis J; 2015 Jun; 34(6):621-6. PubMed ID: 25973940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nontypeable Haemophilus influenzae protein E (PE) as a microbial adjuvant on the amount of antibody against PRP of Haemophilus influenzae type b (Hib) in BALB/c mice.
    Tavakoli M; Bouzari S; Jafari A; Oloomi M; Asadi Karam MR; Najar-Peerayeh S; Siadat SD
    Microb Pathog; 2019 Apr; 129():78-81. PubMed ID: 30682526
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.
    Talan DA; Moran GJ; Pinner RW
    Ann Emerg Med; 1999 Jul; 34(1):109-11. PubMed ID: 10382005
    [No Abstract]   [Full Text] [Related]  

  • 20. Avidity of Haemophilus influenzae type b antibody in UK infants.
    Berrington JE; Fenton AC; Arnaoutakis K; Zhang Q; Finn A
    Arch Dis Child; 2007 Sep; 92(9):827. PubMed ID: 17715451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.